磷酸和硫代磷酸三环香豆素类似物作为STS抑制剂的关键结构特征鉴定

Srimathi Radha , K. Kathiravan Muthu
{"title":"磷酸和硫代磷酸三环香豆素类似物作为STS抑制剂的关键结构特征鉴定","authors":"Srimathi Radha ,&nbsp;K. Kathiravan Muthu","doi":"10.1016/j.medidd.2021.100108","DOIUrl":null,"url":null,"abstract":"<div><p>Steroidal sulfatase (STS) is a group of arylsulfatase C enzymes that are involved in the metabolism of steroids. The increase in the circulation of the steroidogenic hormone Estradiol (E2) is responsible for causing breast cancer. Therefore, inhibitors of STS are proved to be an attractive target in the development of lead molecules against breast malignancy. In this work, Quantitative Structural Activity Relationship (QSAR) studies were performed on a dataset of 72 molecules of tricyclic coumarin analogs using random selection in QSARINS software and the statistical technique Genetic Algorithm coupled Multiple Linear Regression (MLR) was employed with the best model prediction R<sup>2</sup> = 0.86 and Q<sup>2</sup><sub>loo</sub> = 0.7913. The inclusion of descriptors Mor15m and Mor18v has developed a well-fitted and highly predictable model. Furthermore, the molecular docking and dynamics simulations helped us identify the binding interactions and estimate the stability of the complexes respectively. The binding analysis of the compounds into human sulfatase protein (PDB code: 1P49) resulted in prominent hydrophobic interactions with Arg98, Val486, Phe488, Gly100, Val101, and Lys368. The top-scoring compound 9o and compound 41 were studied for stability analysis in comparison with the standard Irosustat and the RMSD was found to be 5.4 Å. Based on our findings, we report the inclusion of the necessary structural features of coumarin derivatives leads to the development of potent candidates for further development.</p></div>","PeriodicalId":33528,"journal":{"name":"Medicine in Drug Discovery","volume":"12 ","pages":"Article 100108"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590098621000294/pdfft?md5=3f6e6bf0d05630f13226492b08100c61&pid=1-s2.0-S2590098621000294-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Identification of key structural features of phosphate and thiophosphate tricyclic coumarin analogs as STS inhibitors\",\"authors\":\"Srimathi Radha ,&nbsp;K. Kathiravan Muthu\",\"doi\":\"10.1016/j.medidd.2021.100108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Steroidal sulfatase (STS) is a group of arylsulfatase C enzymes that are involved in the metabolism of steroids. The increase in the circulation of the steroidogenic hormone Estradiol (E2) is responsible for causing breast cancer. Therefore, inhibitors of STS are proved to be an attractive target in the development of lead molecules against breast malignancy. In this work, Quantitative Structural Activity Relationship (QSAR) studies were performed on a dataset of 72 molecules of tricyclic coumarin analogs using random selection in QSARINS software and the statistical technique Genetic Algorithm coupled Multiple Linear Regression (MLR) was employed with the best model prediction R<sup>2</sup> = 0.86 and Q<sup>2</sup><sub>loo</sub> = 0.7913. The inclusion of descriptors Mor15m and Mor18v has developed a well-fitted and highly predictable model. Furthermore, the molecular docking and dynamics simulations helped us identify the binding interactions and estimate the stability of the complexes respectively. The binding analysis of the compounds into human sulfatase protein (PDB code: 1P49) resulted in prominent hydrophobic interactions with Arg98, Val486, Phe488, Gly100, Val101, and Lys368. The top-scoring compound 9o and compound 41 were studied for stability analysis in comparison with the standard Irosustat and the RMSD was found to be 5.4 Å. Based on our findings, we report the inclusion of the necessary structural features of coumarin derivatives leads to the development of potent candidates for further development.</p></div>\",\"PeriodicalId\":33528,\"journal\":{\"name\":\"Medicine in Drug Discovery\",\"volume\":\"12 \",\"pages\":\"Article 100108\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590098621000294/pdfft?md5=3f6e6bf0d05630f13226492b08100c61&pid=1-s2.0-S2590098621000294-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine in Drug Discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590098621000294\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine in Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590098621000294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

甾体磺化酶(STS)是一组参与类固醇代谢的芳基磺化酶C。促甾体激素雌二醇(E2)循环的增加是导致乳腺癌的原因。因此,STS抑制剂被证明是开发抗乳腺恶性肿瘤先导分子的一个有吸引力的靶点。本文在QSARINS软件中对72个三环香豆素类似物分子进行了定量结构活性关系(Quantitative Structural Activity Relationship, QSAR)研究,采用遗传算法耦合多元线性回归(Genetic Algorithm coupled Multiple Linear Regression, MLR)进行统计分析,最佳模型预测R2 = 0.86, Q2loo = 0.7913。描述符Mor15m和Mor18v的加入形成了一个拟合良好且高度可预测的模型。此外,分子对接和动力学模拟分别帮助我们识别结合相互作用和估计配合物的稳定性。这些化合物与人硫酸酯酶蛋白(PDB代码:1P49)的结合分析表明,它们与Arg98、Val486、Phe488、Gly100、Val101和Lys368存在明显的疏水相互作用。将得分最高的化合物90和化合物41与标准Irosustat进行稳定性分析,发现RMSD为5.4 Å。基于我们的研究结果,我们报告了香豆素衍生物的必要结构特征的包含导致了进一步开发的有力候选物的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Identification of key structural features of phosphate and thiophosphate tricyclic coumarin analogs as STS inhibitors

Steroidal sulfatase (STS) is a group of arylsulfatase C enzymes that are involved in the metabolism of steroids. The increase in the circulation of the steroidogenic hormone Estradiol (E2) is responsible for causing breast cancer. Therefore, inhibitors of STS are proved to be an attractive target in the development of lead molecules against breast malignancy. In this work, Quantitative Structural Activity Relationship (QSAR) studies were performed on a dataset of 72 molecules of tricyclic coumarin analogs using random selection in QSARINS software and the statistical technique Genetic Algorithm coupled Multiple Linear Regression (MLR) was employed with the best model prediction R2 = 0.86 and Q2loo = 0.7913. The inclusion of descriptors Mor15m and Mor18v has developed a well-fitted and highly predictable model. Furthermore, the molecular docking and dynamics simulations helped us identify the binding interactions and estimate the stability of the complexes respectively. The binding analysis of the compounds into human sulfatase protein (PDB code: 1P49) resulted in prominent hydrophobic interactions with Arg98, Val486, Phe488, Gly100, Val101, and Lys368. The top-scoring compound 9o and compound 41 were studied for stability analysis in comparison with the standard Irosustat and the RMSD was found to be 5.4 Å. Based on our findings, we report the inclusion of the necessary structural features of coumarin derivatives leads to the development of potent candidates for further development.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicine in Drug Discovery
Medicine in Drug Discovery Medicine-Pharmacology (medical)
CiteScore
8.30
自引率
0.00%
发文量
30
审稿时长
21 days
期刊介绍:
期刊最新文献
Recent approaches in nanotoxicity assessment for drug delivery applications: Challenges and prospects Structural features of arrestin-mediated GPCR signaling The distribution of Hypocretin/Orexin receptor mRNA in the mouse and human brain Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials Pharmacological effects of dragon’s blood from Dranaena cochinchinensis (Lour.) S.C. Chen and its application in cardiovascular diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1